Insmed Incorporated Stock Pitch
DOI:
https://doi.org/10.58445/rars.1383Keywords:
Insmed, Stock, InvestmentsAbstract
Insmed Incorporated is a biopharmaceutical company out of Bridgewater, New Jersey that specializes in the development and commercialization of therapies and cures for rare and serious diseases. Their key product is called ARIKAYCE and is the only FDA-approved medication that can treat refractory Mycobacterium avium complex (MAC) lung disease. The product is representative of a significant advancement in respiratory care and a commitment by Insmed Incorporated to continue to achieve groundbreaking discoveries in the medical field. Some of Insmed’s other products that are in the works include Brensocatib for bronchiectasis and Treprostinil Palmitil for pulmonary arterial hypertension, both products targeting the market of diseases and conditions that do not yet have a cure. By targeting a relatively untapped market, Insmed has opened more doors within the biopharmaceutical industry, making a name for itself as an attractive investment opportunity.
References
Yahoo Finance. "Insmed Incorporated (INSM) Stock Price, News, Quote & History." Yahoo Finance, Yahoo.
Accessed July 20, 2024.
URL: https://finance.yahoo.com/quote/INSM
Insmed Incorporated. "Investor Relations." Insmed Incorporated.
Accessed July 20, 2024.
URL: https://investor.insmed.com/
U.S. Securities and Exchange Commission. "Company Search Results for Insmed Incorporated." EDGAR, U.S. Securities and Exchange Commission.
Accessed July 20, 2024.
URL: https://www.sec.gov/edgar/searchedgar/companysearch.html
Morningstar. "Insmed Incorporated (INSM) Quote." Morningstar.
Accessed July 20, 2024.
URL: https://www.morningstar.com/stocks/xnas/insm/quote
Zacks Investment Research. "Insmed Incorporated (INSM)." Zacks Investment Research.
Accessed July 20, 2024.
URL: https://www.zacks.com/stock/quote/INSM
Insmed Incorporated. "Newsroom." Insmed Incorporated.
Accessed July 20, 2024.
URL: https://investor.insmed.com/news-releases
MarketWatch. "Insmed Incorporated (INSM) Stock Price & News." MarketWatch.
Accessed July 20, 2024.
Additional Files
Posted
Categories
License
Copyright (c) 2024 Matthew Trudell
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license
